ABSTRACT Low-energy electromagnetic fields pulsed at frequencies of 10-90 Hz significantly increase healing ofchronic fracture nonunions in man. These fields are effective at tissue current levels several orders of magnitude lower than those required for transmembrane depolarization ofnormal cells. We have examined the effects of two clinically used pulsed electromagnetic fields on cultures of the osteoblast-like mouse bone cell line MMB-1. Both fields significantly reduced cellular production of cAMP in response to parathyroid hormone and osteoclast activating factor. Neither basal nor fluoride-activated levels of adenylate cyclase were altered in membranes from cells cultured in the fields; however, the same membrane -preparations exhibited markedly inhibited responses to parathyroid hormone. The fields blocked the inhibitory effects of the hormone on collagen synthesis by MMB-1 cells. However, there was no effect on the inhibition of collagen synthesis by 1,25-dihydroxyvitamin D3, which is believed to act primarily by a nuclear, rather than by a membrane-dependent, mechanism. No significant differences were noted between effects of the two fields, one generating continuous pulse trains (72 Hz) and the other generating recurrent bursts (15 Hz) of shorter pulses. We hypothesize that these field effects are mediated primarily at the plasma membrane of osteoblasts, either by interference with hormone-receptor interactions or by blocking of receptor-cyclase coupling in the membrane. These responses occurred with induced extracellular fields of 1 mV/cm or less, even though transmembrane potential gradients are typically 105 V/cm.
Clinical studies (1) (2) (3) (4) (5) have demonstrated the usefulness ofelectromagnetic fields in stimulatinghealing ofchronically ununited fractures in humans. Devices generating such fields have been approved for clinical use. However, the mechanisms of action of these fields are not clear. Oscillating electromagnetic fields proven effective in clinical use generate electrochemical gradients in the tissue fluid surrounding cells (6) , but these gradients are considerably weaker than the levels required to depolarize cell membranes. Typically, the devices in question impose -20-G pulsed magnetic fields, which induce current densities of -1 uA/cm2 and associated electric gradients of 1-10 mV/cm in extracellular fluids (2) . Because of the high resistance ofcell membranes, any transmembrane electrical components ofimposed fields would be lower than the extracellular gradients by two to three orders of magnitude (6) and thus as much as six orders of magnitude less than the typical excitatory threshold currents of 1 mA/cm2 observed for axonal depolarization (7) .
It would therefore appear that the effectiveness ofsuch weak stimuli in generating cellular processes must depend on a series of amplification mechanisms, either before or during the transmembrane coupling of the initial stimulus (8) . Likely loci for amplification and extension of weak electrochemical triggering events at the cell membrane may involve glycoprotein molecules on the external surface of the plasma membrane (9) , especially those molecules that constitute specific receptor sites for various extracellular molecules. In the present study, we have cultured bone and bone cells in the presence of clinically useful electromagnetic fields and have examined the responses of the cells to hormones that either do or do not appear to act primarily via plasma membrane receptors. The data are consistent with substantial changes in the activity of membrane processes as a result of exposure to the fields, suggesting that the clinical effectiveness of the fields may be mediated by changes in the sensitivity of cells in vivo to endogenous hormones. In addition, the data appear to be consistent with previously proposed nonequilibrium models for the responses of cells to weak electrochemical stimuli.
MATERIALS AND METHODS
For experiments in which isolated bones were cultured, the cranial.bones were dissected from 3-day-old mice and cultured as described (10) . For monolayer osteoblast cultures, the bone cells used were the MMB-1 osteoblast-like cell line developed in this laboratory (11) Hormones were added and assays-cAMP accumulation, adenylate cyclase activity, and collagen synthesis-were carried out as described (10) . Hormones used for the studies were bovine parathyroid hormone (1-34) (PTH) synthetic peptide (Bachem Fine Chemicals, Torrance, CA), osteoclast-activating factor (OAF) prepared in this laboratory (12) , and 1,25-dihydroxyvitamin D3 (Hoffmnann-La Roche).
The general characteristics of the electromagnetic fields in these experiments have been described (13) . The (14) and in its synaptosomal fractions (15) and are similarly ineffective in modulating cell-mediated cytotoxicity of T lymphocytes (16) , phenomena that are -strongly responsive to radio and microwave fields amplitude modulated at frequencies <100 Hz. We have confirmed that these fields produced an electrical gradient of ==I.O mV/cm around a 1-cm ioop in the spatially homogeneous portion ofthe field between the coils and that the expected peak extracellular current density in homogeneous conducting electrolytes would be =zzl.0 pA/cm2 ('13 (6) . The membranes were treated for 10 min with the indicated concentrations of PTH without exposure to the field, and then the production of cAMP was determined. Results are mean SEM. The specific inhibition ofcollagen synthesis by PTH (18) was blocked by treatment ofcells with the fields (Fig. 2) . However, the fields did not block the effects on collagen synthesis of 1,25-dihydroxyvitamin D3, a hormone that apparently acts via a cytoplasmic rather than a membrane receptor (19) . As with cell cultures, isolated mouse cranial bones exhibited significantly decreased accumulation of cAMP when treated with PTH or OAF after culture in the fields (Table 3) .
DISCUSSION
It is reasonable to postulate that the osteoblast, the bone forming cell, is specifically sensitive to electromagnetic fluxes of (5) . The present data suggest that the effects of fields on bone involve subtle changes in the response of bone cells to their surroundings. The ability of the bone cells to respond to added PTH or OAF with increased cAMP formation was inhibited dramatically by the fields; the same result was observed for isolated mouse cranial bones cultured under similar conditions. Since the effects of short-term treatment with PTH are osteolytic, blocking of the effects of PTH in vivo should lead to net increases in the rate ofbone formation. In a case in which only small localized areas ofbone are rendered resistant to PTH action, there would likely be no significant changes in the overall circulating concentrations of calcium or PTH, leading to increased bone density in the affected areas without systemic effects on mineral balance. This in fact has been observed clinically (1, 2) .
The current results do not directly indicate the electrochemical mechanism by which osteoblasts respond to electromagnetic fields. However, the evidence points to the cell membrane as a primary site of interaction. Although the fields inhibited the activities ofthe peptide agents PTH and OAF, we did not observe changes in the activity of 1,25-dihydroxyvitamin D3, a hormone that does not appear to act via plasma membrane receptors (19) . In addition, the earliest enzyme involved in PTH action, PTH-activated plasma membrane adenylate cyclase, was substantially inhibited by the fields. In contrast, the total amount ofadenylate cyclase catalytic units in the membrane (as assessed by activation with fluoride) was not decreased, nor was the basal cyclase activity altered by exposure ofcells to the field. This finding argues against long-term direct effects of the fields on the cyclase itself and suggests that the fields may be interfering with the binding of hormone to receptor, the ability of the hormone-receptor complex to activate cyclase, or both.
Another possible locus for the effects of electromagnetic fields is the coupling of the hormone-receptor complex to adenylate cyclase in the membrane. Such an effect could be mediated either directly, by effects on the intrinsic membrane coupling protein(s) (20) (21) and, conversely, some of the hormonal actions of PTH may be mimicked by calcium ionophores (22) . Recent findings (23) indicate that calcium influx in bone cells may be linked with a Na+-Ca2+ exchange mechanism and thus with the transmembrane gradients of Na+ and K+ maintained by the Na+/K+ ATPase pump. These findings are supported by previous studies of the effects of electromagnetic fields on the binding and release of Ca2+ in isolated cerebral tissue (13, 24, 25) , in cerebral synaptosome fractions (14) , in pancreatic islets (26) , and in modification of cytotoxity of T lymphocytes exposed to low-frequency modulated microwave fields (15) . There is evidence that initial events in coupling of weak oscillating electromagnetic fields to cell membranes occur on membrane surface polyanionic glycoproteins, producing transient coherent states of nearest-neighbor fixed-charge sites (27) . These coherent states may exist for considerable distances along the membrane surface (28) , and thus would appear likely sites for the first steps in transductive coupling. Binding and release of Ca2" at these membrane surface sites correlate closely with exposure to certain weak electromagnetic fields. Sensitivity to these fields in narrow frequency and amplitude "windows" (14, (29) (30) (31) supports a series of models based on cooperative or dissipative interactions at cell membrane surface glycoproteins.
Evidence from Ca2+-H' interactions in the presence of these fields raised the possibility of proton tunneling, perhaps at the margins between coherent and incoherent fixed-charge zones (25) . Dispersive (reaction-diffusion) interactions may also occur at cell membrane surfaces between linear macromolecules and electromagnetic fields (32) (33) (34) in the form of soliton waves and act as a substrate for coupling extracellular events to the intracellular domain (35) . It 
